|
OTUD7B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.484100E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.995600E-01 |
| Normal-vs-Stage2 |
6.508300E-02 |
| Normal-vs-Stage3 |
3.73449999999664E-05 |
| Normal-vs-Stage4 |
6.07080000000204E-05 |
| Stage1-vs-Stage2 |
1.957040E-01 |
| Stage1-vs-Stage3 |
3.587600E-04 |
| Stage1-vs-Stage4 |
1.156930E-03 |
| Stage2-vs-Stage3 |
2.492400E-01 |
| Stage2-vs-Stage4 |
1.719380E-01 |
| Stage3-vs-Stage4 |
6.683000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.281100E-03 |
| Normal-vs-AfricanAmerican |
1.607160E-01 |
| Normal-vs-Asian |
5.771400E-01 |
| Caucasian-vs-AfricanAmerican |
9.827800E-01 |
| Caucasian-vs-Asian |
1.165180E-01 |
| AfricanAmerican-vs-Asian |
2.710800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.445300E-04 |
| Normal-vs-Female |
2.389600E-01 |
| Male-vs-Female |
2.449800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.053800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.073700E-02 |
| Normal-vs-Age(61-80Yrs) |
3.849600E-04 |
| Normal-vs-Age(81-100Yrs) |
3.792000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.712200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.790400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.605800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.225620E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.957800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.931200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.654100E-02 |
| Normal-vs-Grade 2 |
4.452000E-01 |
| Normal-vs-Grade 3 |
8.804700E-04 |
| Normal-vs-Grade 4 |
2.93849999888351E-08 |
| Grade 1-vs-Grade 2 |
8.799700E-02 |
| Grade 1-vs-Grade 3 |
5.244700E-03 |
| Grade 1-vs-Grade 4 |
1.7234699999924E-05 |
| Grade 2-vs-Grade 3 |
8.622100E-03 |
| Grade 2-vs-Grade 4 |
3.5302000001014E-07 |
| Grade 3-vs-Grade 4 |
4.644600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.854000E-01 |
| Normal-vs-ccB subtype |
1.407450E-04 |
| ccA subtype-vs-ccB subtype |
3.81760000001119E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.484200E-03 |
| Normal-vs-N1 |
9.55459999999464E-05 |
| N0-vs-N1 |
7.765800E-02 |
|
|
